Penumbra Priced, NYSE: PEN

Markets devices for the treatment of strokes and other vascular conditions.

Industry: Health Care

Latest Trade: $81.10 0.00 (0.0%)

First Day Return: +37.7%

Return from IPO: +170.3%

Industry: Health Care

Penumbra is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. We have a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. We are an established company focused on the neuro market, and we recently expanded our business to include the peripheral vascular market. We focus on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. We design our products to provide these specialist physicians with a means to drive improved clinical outcomes through faster and safer procedures.
more less
IPO News for Penumbra
more
IPO Data
IPO File Date 08/14/2015
Offer Price $30.00
Price Range $25.00 - $28.00
Offer Shares (mm) 4.0
Deal Size ($mm) $120
IPO Data
IPO Date 09/17/2015
Offer Price $30.00
Price Range $25.00 - $28.00
Offer Shares (mm) 4.0
Deal Size ($mm) $120
Underwriters
more
Company Data
Headquarters Alameda, CA
Founded 2004
Employees 1,000
Website www.penumbrainc.com